Target intelligence / Profile preview

Treacle ribosome biogenesis factor 1 (TCOF1)

Target
TCOF1
Molecular classification
Nucleolar phosphoprotein, Ribosome biogenesis factor, Other
01

Overview

Treacle ribosome biogenesis factor 1 (TCOF1) encodes **treacle**, a nucleolar phosphoprotein crucial for ribosomal RNA (rRNA) gene transcription and ribosome biogenesis[1][2][3][4][5]. The protein is essential for normal embryonic development of facial bones and tissues, acting primarily by regulating cellular rRNA production and thereby protein biosynthesis, cell proliferation, and apoptosis[1][2][4][5]. Treacle is also implicated in DNA damage response, cooperating with factors such as NBS1 and ATM to promote cellular resistance to genotoxic stress and maintain genomic stability[6][2]. Mutations in **TCOF1** cause Treacher Collins syndrome, a congenital disorder with variable craniofacial malformations, and are increasingly recognized as relevant in other pathologies, including cancer[2][6]. There are no drugs that directly target TCOF1, and it is not currently considered an established therapeutic target. Nevertheless, because of its central roles in ribosome biogenesis and genome stability, TCOF1 is of interest in developmental biology, cancer research, and genetic diagnostics[2][5][6].

Other names
Treacle proteintreacleTCSTreacher Collins syndrome proteinMFD1TCS1Treacher Collins-Franceschetti syndrome 1nucleolar trafficking phosphoproteinTCOF_HUMAN
02

Biological functions

Ribosomal RNA (rRNA) gene transcriptionRibosome biogenesisCell cycle regulationProliferationDNA damage responseApoptosisEmbryonic craniofacial development
03

Disease associations

Craniofacial disorder (Treacher Collins syndrome)CancerOther developmental disorders (e.g., Hirschsprung disease, possible neural crest-related pathologies)
04

Safety considerations

TCOF1 mutations lead to developmental defects, primarily craniofacial abnormalitiesPossible roles in cancer biology and resistance to therapies (therapeutic on-target effects undefined)
05

Biomarkers

Mutations in TCOF1 as diagnostic for Treacher Collins syndrome

Beyond the preview

Go deeper on Treacle ribosome biogenesis factor 1 (TCOF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Treacle ribosome biogenesis factor 1 (TCOF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call